PhD Atsuhiro Sakamoto MD

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Second-line therapy has limited activity in patients with recurrent or persistent uterine cervical cancer that has progressed after chemoradiation and palliative chemotherapy. The purpose of this study was to evaluate the efficacy of negative-balance isolated pelvic perfusion (NIPP) in patients with pretreated recurrent/persistent uterine cervical cancer.(More)
  • 1